TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29055966

Group type: EXPERIMENTAL
Intervention: PNIF
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: unilateral PNIF
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AAR
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PNIF and AAR
Number of subjects: 20
Study: 26555953

Group type: EXPERIMENTAL
Intervention: External physical vibration lithecbole after shock wave lithotripsy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Shock wave lithotripsy only
Number of subjects: 71
Study: 25062395

Group type: EXPERIMENTAL
Intervention: HAS‐BLED score and estimated annual risk of bleeding
Number of subjects: 203

Group type: COMPARATOR
Intervention: No HAS‐BLED score
Number of subjects: 203
Study: 23019938

Group type: EXPERIMENTAL
Intervention: Compound Xuanju Capsule (CXC) and Clomiphene Citrate (CC)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC) alone
Number of subjects: 87
Study: 20081549

Group type: EXPERIMENTAL
Intervention: Subjective Refraction (SR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: AdSpecs
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Focometer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Predetermined Lens Refraction (PLR)
Number of subjects: 100
Study: 17901792

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 2523

Group type: COMPARATOR
Intervention: Nonfluoroquinolone antibiotics
Number of subjects: 2523
Study: 16213381

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (five weekly intra-articular injections)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phosphate-buffered saline (control)
Number of subjects: 0
Study: 11825860

Group type: EXPERIMENTAL
Intervention: 50 mg GHB/kg body wt
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 100 mg GHB/kg body wt
Number of subjects: 98

Group type: COMPARATOR
Intervention: clomethiazole 1000 mg daily (CLO group)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: GHB (both dosages)
Number of subjects: 98
Study: 10553535

Group type: EXPERIMENTAL
Intervention: Gangliosides treatment (100 mg/day for 15 days followed by 40 mg/day for 75 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gangliosides treatment (continuous treatment for 12 months)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gangliosides treatment
Number of subjects: 90
Study: 7793220

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 50
Study: 1869064

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (30 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6132179

Group type: EXPERIMENTAL
Intervention: melphalan 6 mg/m2 daily for 5 days every 6 weeks for sixteen cycles
Number of subjects: 370

Group type: COMPARATOR
Intervention: no additional treatment
Number of subjects: 370
Study: 31027423

Group type: EXPERIMENTAL
Intervention: Aligners
Number of subjects: 40

Group type: COMPARATOR
Intervention: Labial fixed appliances
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 30684327

Group type: EXPERIMENTAL
Intervention: 10 whole-body cryotherapy treatments associated with 30-minute kinesitherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Kinesitherapy only (control group)
Number of subjects: 48
Study: 26582640

Group type: EXPERIMENTAL
Intervention: Treadmill walking in water
Number of subjects: 10

Group type: COMPARATOR
Intervention: Treadmill walking on land
Number of subjects: 10
Study: 24781074

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 830

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 830
Study: 22331457

Group type: EXPERIMENTAL
Intervention: Grewia oppositifolia leaves
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cottonseed cake (CSC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (local pasture only)
Number of subjects: 36
Study: 20702659

Group type: EXPERIMENTAL
Intervention: Acyclovir (400 mg twice daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 17383494

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Training (PMRT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Attention placebo (control)
Number of subjects: 121
Study: 15802370

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Phenylephrine (alpha(1)-agonist)
Number of subjects: 19
Study: 12375540

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Estrogen cream
Number of subjects: 128

Group type: COMPARATOR
Intervention: Inert lubricant jelly (Control)
Number of subjects: 128
Study: 9640069

Group type: EXPERIMENTAL
Intervention: Pelentan (Hypoprothrombinemia Provocation Test) administered to patients with suspected hepatic injury and alcohol abusers
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Pelentan (Hypoprothrombinemia Provocation Test) administered
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Pelentan (Hypoprothrombinemia Provocation Test)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group (clinically healthy people not exposed to toxic agents)
Number of subjects: 172
Study: 7521534

Group type: EXPERIMENTAL
Intervention: Risperidone 4 mg/day
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Risperidone 8 mg/day
Number of subjects: 88

Group type: COMPARATOR
Intervention: Haloperidol 10 mg/day
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 88
Study: 2729124

Group type: EXPERIMENTAL
Intervention: Dilevalol 200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31493725

Group type: EXPERIMENTAL
Intervention: tDCS applied during MT (concurrent‐tDCS group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: tDCS applied before MT (prior‐tDCS group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS (sham‐tDCS group)
Number of subjects: 30
Study: 28254097

Group type: EXPERIMENTAL
Intervention: Acupuncture (Acp)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Acupuncture and Moxibustion (Acp-Mox)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control
Number of subjects: 7
Study: 26025699

Group type: EXPERIMENTAL
Intervention: Electronic reminders for clinical appointments
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 200
Study: 22748085

Group type: EXPERIMENTAL
Intervention: Manual chest physiotherapy (MCP) plus advice on airway clearance
Number of subjects: 526

Group type: COMPARATOR
Intervention: Advice on chest clearance alone
Number of subjects: 526
Study: 20038724

Group type: EXPERIMENTAL
Intervention: CEF (cyclophosphamide, epirubicin, and fluorouracil)
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: 2T (TOP2A with TIMP‐1)
Number of subjects: 980

Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, and fluorouracil)
Number of subjects: 980
Study: 18387567

Group type: EXPERIMENTAL
Intervention: Finger-differentiation training programme (G1) - 2 weekly sessions of half an hour each for 8 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control-intervention (story comprehension training, G2)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Normal school lessons (G3)
Number of subjects: 47
Study: 15770171

Group type: EXPERIMENTAL
Intervention: Tailored interventions including the Dutch low back pain guideline, a 2-hour educational workshop, scientific articles, and tools for patient education and agreement on low back care
Number of subjects: 531

Group type: COMPARATOR
Intervention: Control group received no intervention
Number of subjects: 531
Study: 12176950

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 238

Group type: COMPARATOR
Intervention: Uncoated stent
Number of subjects: 238
Study: 10027429

Group type: EXPERIMENTAL
Intervention: Zafirlukast (20 mg twice daily)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Zafirlukast (20 mg twice daily) with PEF variability >= 20%
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Zafirlukast (20 mg twice daily) with PEF variability < 20%
Number of subjects: 261
Study: 7570569

Group type: EXPERIMENTAL
Intervention: Cell washing (CS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Whole blood filtration (WB)
Number of subjects: 20
Study: 2405348

Group type: EXPERIMENTAL
Intervention: trimethoprim‐sulfamethoxazole for 4 weeks
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: prednisone for 2 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: aluminum ibuprofen suspension for 2 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: control (no treatment)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: all groups after 12 months follow-up
Number of subjects: 76
Study: 7008643

Group type: EXPERIMENTAL
Intervention: Domperidone 10 mg I.V.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31933343

Group type: EXPERIMENTAL
Intervention: ECC+BFR (30% 1-RM, 3x20 repetitions)
Number of subjects: 17

Group type: COMPARATOR
Intervention: ECC (60% 1-RM, 3x10 repetitions)
Number of subjects: 17
Study: 30467609

Group type: EXPERIMENTAL
Intervention: Dynamic electronic cognitive aid (dCA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Static cognitive aid (sCA)
Number of subjects: 34
Study: 27129358

Group type: EXPERIMENTAL
Intervention: Seligman PPI
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Fordyce PPI
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lyubomirsky PPI
Number of subjects: 69

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 69
Study: 24737272

Group type: EXPERIMENTAL
Intervention: Statin rechallenge
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 22986242

Group type: EXPERIMENTAL
Intervention: Denture microwave disinfection (1 or 3 times/week for 14 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical antifungal therapy (nystatin, 1 or 3 times/week for 14 days)
Number of subjects: 60
Study: 20350598

Group type: EXPERIMENTAL
Intervention: Transdermal patches with polyacrylate pressure sensitive adhesives
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Probe tack test
Number of subjects: 8
Study: 18671241

Group type: EXPERIMENTAL
Intervention: Amifostine (500 mg subcutaneously 3 times weekly)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Epoetin-alpha (10,000 IU subcutaneously 3 times weekly)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 76
Study: 15562376

Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/d for 24 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12006958

Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 10232569

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced MR angiography
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intra-arterial DSA (control)
Number of subjects: 24
Study: 7532192

Group type: EXPERIMENTAL
Intervention: Casein stimulation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Candida albicans stimulation
Number of subjects: 7

Group type: COMPARATOR
Intervention: L-selectin expression
Number of subjects: 7
Study: 1646613

Group type: EXPERIMENTAL
Intervention: Single oral doses of apafant (20 mg to 400 mg)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Multiple oral doses of apafant (100 mg t.i.d. over 7 days)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of apafant (0.5 to 50 mg over 30 min)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Inhalative administration of apafant (up to 1.0 mg)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Oral administration of apafant (capsules)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: General safety profile of apafant
Number of subjects: 101
Study: 7148760

Group type: EXPERIMENTAL
Intervention: Pancrealipase (pH-sensitive microspheres)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cotazym (encapsulated enzyme powder)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enteric-coated product (Pancrealipase)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both enzyme preparations
Number of subjects: 10
Study: 31721237

Group type: EXPERIMENTAL
Intervention: DRSK replica
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: DENTALIKE replica
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TrueTooth replica
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tooth replicas based on microCT scans (TrueTooth and DENTALIKE)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall performance
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Inter-rater reliability
Number of subjects: 50
Study: 29669748

Group type: EXPERIMENTAL
Intervention: 0 mg/mL e-liquid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6 mg/mL e-liquid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12 mg/mL e-liquid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 24 mg/mL e-liquid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: e-liquid (various strengths)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: e-liquid nicotine strength
Number of subjects: 0
Study: 27922279

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (cetrorelix) at low dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: hMG only (control group)
Number of subjects: 0
Study: 26404365

Group type: EXPERIMENTAL
Intervention: High oleic peanuts (15%-20% of energy)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nut free diet
Number of subjects: 61
Study: 24806038

Group type: EXPERIMENTAL
Intervention: Stochastic resonance whole-body vibration training for 8 weeks
Number of subjects: 124

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 124
Study: 22883107

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard conventional radiotherapy (CRT)
Number of subjects: 67
Study: 19234342

Group type: EXPERIMENTAL
Intervention: Sub-Tenon's injection of 25 mg triamcinolone and 2 mg ciprofloxacin in biodegradable microspheres
Number of subjects: 135

Group type: COMPARATOR
Intervention: Prednisolone 1% and ciprofloxacin 3% eye drops
Number of subjects: 135
Study: 17768459

Group type: EXPERIMENTAL
Intervention: Standard plus relaxation therapy, 2 times per week, for 8 weeks
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 220
Study: 15961676

Group type: EXPERIMENTAL
Intervention: Undernourished patients with anorexia nervosa
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Undernourished patients with coexistent disease
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Refeeding in disease patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Refeeding in anorexia patients
Number of subjects: 42
Study: 12439918

Group type: EXPERIMENTAL
Intervention: Intravenous chemotherapy after gastrectomy
Number of subjects: 4543

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 4543
Study: 10506849

Group type: EXPERIMENTAL
Intervention: recombinant tissue‐Plasminogen Activator (rt‐PA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: streptokinase
Number of subjects: 40
Study: 7577778

Group type: EXPERIMENTAL
Intervention: 0.05% bupivacaine at 10 mL/h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine at 10 mL/h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.01% bupivacaine at 10 mL/h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1 mg/h bupivacaine
Number of subjects: 24
Study: 2337209

Group type: EXPERIMENTAL
Intervention: Xenon
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nitrous Oxide
Number of subjects: 32
Study: 83475

Group type: EXPERIMENTAL
Intervention: Inactivated influenza-A vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revaccination with the same strain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revaccination with a later strain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual revaccination with inactivated influenza-A vaccine
Number of subjects: 0
Study: 31519804

Group type: EXPERIMENTAL
Intervention: 177Lu-PP-F11N
Number of subjects: 6

Group type: COMPARATOR
Intervention: 177Lu-PP-F11N without SG
Number of subjects: 6

Group type: COMPARATOR
Intervention: 177Lu-PP-F11N with SG
Number of subjects: 6
Study: 31071464

Group type: EXPERIMENTAL
Intervention: Treadmill-based aerobic exercise intervention (supervised for 4 weeks followed by unsupervised home exercise for 6 months)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Treadmill-based aerobic exercise intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 70
Study: 28916367

Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice daily
Number of subjects: 564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 564
Study: 24913600

Group type: EXPERIMENTAL
Intervention: Brief adherence intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 23789838

Group type: EXPERIMENTAL
Intervention: Vacuum and IPL
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: IPL
Number of subjects: 180

Group type: COMPARATOR
Intervention: Topical treatment with Sebium H2O Micellaire Solution (Control)
Number of subjects: 180
Study: 21407074

Group type: EXPERIMENTAL
Intervention: tCSA once daily (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: tCSA twice daily (n = 50)
Number of subjects: 100
Study: 19761716

Group type: EXPERIMENTAL
Intervention: Fesoterodine 8 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 17369597

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) for chronic fatigue syndrome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions (two for adults, waiting list for adolescents)
Number of subjects: 0
Study: 15170275

Group type: EXPERIMENTAL
Intervention: Hemorrhage depressors (tranexamic acid and desmopressin)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no hemorrhage depressors)
Number of subjects: 30
Study: 11473555

Group type: EXPERIMENTAL
Intervention: Fresh gas inflow of 1.0 L min-1
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Fresh gas inflow of 2.0 L min-1
Number of subjects: 56
Study: 9724561

Group type: EXPERIMENTAL
Intervention: Ranitidine 75 mg b.i.d. for 8 days
Number of subjects: 2

Group type: COMPARATOR
Intervention: Racemic chlorpheniramine 4 mg single oral dose
Number of subjects: 2
Study: 8056698

Group type: EXPERIMENTAL
Intervention: 400 mg i.v. tds
Number of subjects: 24

Group type: COMPARATOR
Intervention: 750 mg po bd
Number of subjects: 24
Study: 2451231

Group type: EXPERIMENTAL
Intervention: Porous titanium steroid eluting electrode with dexamethasone sodium phosphate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Porous titanium electrode without steroid
Number of subjects: 20
Study: 29992262

Group type: EXPERIMENTAL
Intervention: Patients with atrial fibrillation (AF) during scan
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Patients with non-ischaemic systolic heart failure (including those with AF)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 141
Study: 28559467

Group type: EXPERIMENTAL
Intervention: Trauma group
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: Severe ARDS group
Number of subjects: 2914

Group type: EXPERIMENTAL
Intervention: Aspiration group
Number of subjects: 2914

Group type: COMPARATOR
Intervention: Severity of ARDS (PaO2/FIO2)
Number of subjects: 2914
Study: 26313124

Group type: EXPERIMENTAL
Intervention: Controlled asthma (ACQ7 ≤ 1.5)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Unimproved asthma (ACQ7 > 1.5 at end of study)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Improved asthma control (ACQ7 > 1.5 at randomization and ≤ 1.5 at end of study)
Number of subjects: 221
Study: 22926006

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 260
Study: 20938782

Group type: EXPERIMENTAL
Intervention: High fear of falling (FoF) condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low fear of falling (FoF) condition
Number of subjects: 10
Study: 18516638

Group type: EXPERIMENTAL
Intervention: C-Flex (n = 9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: CPAP (n = 10)
Number of subjects: 19
Study: 16880094

Group type: EXPERIMENTAL
Intervention: Transcatheter ASD closure
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy age-matched children (control)
Number of subjects: 21
Study: 12587122

Group type: EXPERIMENTAL
Intervention: Talinolol (four marketed tablet formulations)
Number of subjects: 36
Study: 10678268

Group type: EXPERIMENTAL
Intervention: 2 mg prazosin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30 mg urapidil
Number of subjects: 12

Group type: COMPARATOR
Intervention: no-drug control state
Number of subjects: 12
Study: 9069061

Group type: EXPERIMENTAL
Intervention: Early discharge from the hospital (home group)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Hospital discharge (hospital group)
Number of subjects: 43
Study: 8156858

Group type: EXPERIMENTAL
Intervention: Tight scleral flap closure with postoperative laser suture lysis (15 eyes)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Loose scleral flap closure (18 eyes)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Laser suture lysis performed in nine patients
Number of subjects: 32
Study: 3539163

Group type: EXPERIMENTAL
Intervention: Epoprostenol infusion (5 ng/kg/min, mean dose 4.9 ng/kg/min, 72 hour infusion)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Epoprostenol infusion
Number of subjects: 45
Study: 29800792

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-based training
Number of subjects: 134

Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 134
Study: 27518321

Group type: EXPERIMENTAL
Intervention: Higher positive end-expiratory pressure (12 cmH2O)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower positive end-expiratory pressure (7 cmH2O)
Number of subjects: 20